Pfizer to buy 8.1% stake in French vaccines company Valneva

📆 20/6/2565 17:36:00
📰 ChannelNewsAsia

⏱ Reading Time:
16 sec. here
2 min. at publisher
📊 Quality Score:
News: 10%
Publisher: 66%

ประเทศไทย ข่าว ข่าว

ประเทศไทย ข่าวล่าสุด,ประเทศไทย หัวข้อข่าว

PARIS: US healthcare giant Pfizer has agreed to invest €90.5 million (US$95.24 million) to buy an 8.1 per cent percent stake in French vaccines company, as the companies announced developments in their partnership to tackle Lyme disease. Pfizer will buy the stake in Valneva, which is also working on

PARIS: US healthcare giant Pfizer has agreed to invest €90.5 million to buy an 8.1 per cent percent stake in French vaccines company, as the companies announced developments in their partnership to tackle Lyme disease.

Valneva and Pfizer also updated the terms of their collaboration and license agreement which they announced on Apr 30, 2020 for the Lyme disease vaccine candidate VLA15. As previously announced on Apr 26, 2022, Pfizer plans to initiate the Phase 3 study of VLA15 in the third quarter of 2022, they added.

เขียนความคิดเห็น

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว